Nyxoah (NYXH) Total Current Liabilities (2020 - 2026)
Nyxoah (NYXH) posted quarterly Total Current Liabilities of $48.1 million for Q1 2026, up 117.89% year-over-year from $22.1 million in Q1 2025, and down 15.66% quarter-over-quarter from $57.0 million in Q4 2025.
Nyxoah (NYXH) Total Current Liabilities (2020 - 2026) Analysis & Trends
Nyxoah's Total Current Liabilities history runs 7 years deep, the most recent figure standing at $48.1 million for Q1 2026.
- In Q1 2026, Total Current Liabilities rose 117.89% year-over-year to $48.1 million; the TTM figure through Mar 2026 stood at $48.1 million (up 117.89% YoY), while the FY2025 annual figure was $57.0 million, up 147.72% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $48.1 million, down from $57.0 million in the prior quarter.
- The five-year high for Total Current Liabilities was $20.2 billion in Q3 2022, with the low at $14.2 million in Q1 2022.
- The 5-year median for Total Current Liabilities is $17.4 million (2024), against an average of $1.4 billion.
- The sharpest annual moves came in 2023 and 2025: Total Current Liabilities plunged 99.92% in 2023, then soared 147.72% in 2025.
- Nyxoah's Total Current Liabilities stood at $15.2 million in 2022, then climbed by 2.14% to $15.5 million in 2023, then soared by 48.04% to $23.0 million in 2024, then jumped by 147.72% to $57.0 million in 2025, then decreased by 15.66% to $48.1 million in 2026.
- Business Quant data shows NYXH's Total Current Liabilities at $48.1 million in Q1 2026, $57.0 million in Q4 2025, and $23.7 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 1.92 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 9.40 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 3.17 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 1.40 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 2.71 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 640.50 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 3.66 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 1.80 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 3.59 Bn |
| 10 | Nyxoah | 90.94 Mn | 90.94 Mn | 5.33 Mn | 54.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 54.94 Mn |
| Mar 31, 2026 | 48.07 Mn |
| Dec 31, 2025 | 56.99 Mn |
| Jun 30, 2025 | 23.71 Mn |
| Mar 31, 2025 | 22.06 Mn |
| Dec 31, 2024 | 23.01 Mn |
| Sep 30, 2024 | 17.37 Mn |
| Jun 30, 2024 | 17.64 Mn |
| Mar 31, 2024 | 15.18 Mn |
| Dec 31, 2023 | 15.54 Mn |
| Sep 30, 2023 | 15.74 Mn |
| Jun 30, 2023 | 16.59 Mn |
| Mar 31, 2023 | 15.39 Mn |
| Dec 31, 2022 | 15.21 Mn |
| Sep 30, 2022 | 20.17 Bn |
| Mar 31, 2022 | 14.19 Mn |
| Dec 31, 2021 | 13.24 Mn |
| Dec 31, 2020 | 7.63 Mn |